Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?
[<sup>177</sup>Lu]Lu-PSMA-617 has recently been successfully approved by the FDA, the MHRA, Health Canada and the EMA as Pluvicto<sup>®</sup>. However, salivary gland (SG) and kidney toxicities account for its main dose-limiting side-effects, while its corresponding uptake an...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |